Trials / Conditions / Advanced or Metastatic Gastric Cancer
Advanced or Metastatic Gastric Cancer
5 registered clinical trials studyying Advanced or Metastatic Gastric Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastr NCT06773312 | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | Phase 1 |
| Unknown | A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer. NCT05188209 | Shanghai Miracogen Inc. | Phase 2 |
| Active Not Recruiting | A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gast NCT04492488 | Shanghai Miracogen Inc. | Phase 1 / Phase 2 |
| Unknown | Study of Metatinib Tromethamine Tablet NCT02650375 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer NCT01512745 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |